However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death ... based Mayo Clinic researchers analyzed the effect GLP-1s and SGLT2s medications had on stroke survivors' risk of ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

GLP-1 receptor agonists, originally developed for managing type ... gained widespread attention for its significant weight ...

GLP-1 receptor agonists, originally developed for managing type ... gained widespread attention for its significant weight ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

The GLP-1 medications liraglutide and semaglutide ... medication use with recurrent stroke and no additional variables. “The potential protective effects of the medications were hidden because those ...